ABSTRACT
Objectives Evaluate procedures for analyzing raw accelerometer data (inertial measurement units) to reconstruct the gait cycle using BioKinetoGraph (BKG). We examine whether footwear and walking surface influence gait (BKG) and evaluate test-retest reliability. We also examine the association between BKG and NIH 4-meter gait, and compare BKG to other neurobehavioral measures for predicting concussion symptoms.
Methods In Study 1, a within-subjects design with 60 participants was used to examine the effects of footwear (shoes/no-shoes) and walking surface (tile floor/grass) on BKG data, and evaluate retest reliability. Study 2 employed a cross-sectional, cohort design of 1,008 participants to assess BKG’s correlation with NIH 4-m gait, and prediction of Centers of Disease Control and Prevention (CDC) concussion symptoms relative to previously validated speed and balance measures.
Results 2×2 ANOVAs illustrate footwear and walking surface effects on BKG for the power, stride, stability, and symmetry, with variable effect sizes. Retest reliability (Pearson rs) for the no shoes/ tile surface condition ranged from .72-.91 (mean = .80, 4-day average interval). BKG correlates significantly with NIH 4-m gait. Regression analyses found BKG predicts CDC concussion symptom endorsement, and outperforms (2-3 fold) BESS and NIH 4-meter gait.
Conclusions Gait assessments should be standardized for footwear and especially walking surface. When standardized (no shoes/hard surface) BKG results in strong test-retest reliability. BKG variables are strongly related to NIH 4-m gait, and are superior to standard measures of gait speed and balance when predicting concussion symptoms; offering additional information when predicting the sequalae of concussion.
What is already known on the topic?
Sensor technology to evaluate gait has established reliability and predicts a wide range of medical outcomes. However, the influence of footwear and walking surface on gait has not been studied, nor has a sensor-based gait assessment been compared to conventional measures for predicting concussion symptoms.
What this study adds?
Gait sensor data is sensitive to footwear and walking surface, but can produce good reliability when these factors are standardized. Gait sensor scores converge with other validated measures of gait, and sensor-based measures of power, stride, symmetry, and stability can outperform established gait speed and balance measures when predicting CDC concussion symptoms.
How this study might affect research, practice, or policy?
Uniform standards for footwear and walking surface are needed when evaluating gait in both research and practice, and sensor-based gait measures can be reliably assessed to provide insight into the behavioral sequelae of concussion, that are superior to simple gait speed.
Competing Interest Statement
The authors report the following conflicts of interest: Williams is co-founder and shareholder of SportGait Inc. Dugan and Zeiger are employed at SportGait Inc, which is part of UNCWs Center for Innovation and Entrepreneurship. Lecci is a paid consultant and minor shareholder for SportGait Inc. Keith, Taravath, and Tseh have no conflicts to report. All authors contributed to the reported studies and manuscript preparation.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of the University of North Carolina Wilmington gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
We thank the many individuals at athletic clubs, universities, and medical clinics who facilitated data collection. Please contact the first author if interested in joining the multi-site research consortium collecting data on baseline and post incident assessments.
There was no external funding for this research.
The authors report the following conflicts of interest: Williams is co-founder and shareholder of SportGait Inc. Dugan and Zeiger are employed at SportGait Inc, which is part of UNCW’s Center for Innovation and Entrepreneurship. Lecci is a paid consultant and minor shareholder for SportGait Inc. Keith, Taravath, and Tseh have no conflicts to report. All authors contributed to the reported studies and manuscript preparation.
Data Availability
All data produced in the present study are available upon reasonable request to the first author
